Glomerular endothelial cells (GEnCs) contribute to renal injuries in IgA nephropathy (IgAN). Here we profiled microRNAs (miRNAs) in GEnCs treated with conditioned medium from human mesangial cells in vitro. Levels of miR-223 in GEnCs decreased after incubation with the medium prepared with pIgA from patients with glomerular endothelial proliferation and were also decreased in the glomerular tissues of patients with glomerular endothelial proliferation. Mesangial-derived IL-6 caused miR-223 levels to decrease. The addition of exogenous miR-223 inhibited cell proliferation, ICAM-1 expression, and monocyte adhesion. The NF-jB and STAT3 signaling pathways collaborate during the activation process. MiR-223 mimics inhibited the nuclear localization and DNA binding of p65 and STAT3 but had no effect on the expression of upstream molecules. Instead, importin a4 and a5 (multipurpose nuclear transport receptors), validated as targets of miR-223, were responsible for the nuclear transport of p65 and STAT3. Importin a4 and a5 siRNA inhibited the nuclear localization of p65 and STAT3 and prevented cell proliferation and monocyte adhesion. The level of miR-223 in circulating endothelial cells was decreased and related to the clinical and pathological parameters. Thus, miR-223 downregulation promotes glomerular endothelial cell activation by upregulating importin a4 and a5 in IgAN. Monitoring the level of miR-223 in circulating endothelial cells may provide a noninvasive method for evaluating the severity of IgAN.
IgA nephropathy (IgAN), one of the most common forms of glomerulonephritis in the world, is characterized by the mesangial deposition of polymeric IgA within the kidneys. [1] [2] [3] Endocapillary hypercellularity is one of the pathological variants of this disease that was found to be associated with disease severity by the Oxford classification study. 4 Diffuse glomerular endothelial proliferation (EP) often occurs concomitantly with extracapillary proliferation and severe proteinuria. 5 Repeat biopsies indicate that the progression of glomerular sclerosis is dependent on the degree of glomerular EP and the severity of cellular crescents at the first biopsy. 6 The microRNAs (miRNAs) modulate protein expression by targeting mRNA transcripts and triggering either translation repression or RNA degradation. 7 Recent insights into disease pathogenesis have revealed that miRNAs play crucial roles in renal diseases. 8 In this study, we profiled the expression of miRNAs in glomerular endothelial cells (GEnCs) treated with IgA-human mesangial cell (HMC) conditioned medium, and found that miR-223 levels decreased in GEnCs treated with the medium prepared with polymeric IgA (pIgA) from patients with glomerular EP. The role of miR-223 in the activation of GEnCs was investigated further. The level of miR-223 in circulating endothelial cells (CECs) was also analyzed to identify whether monitoring miR-223 levels in CECs provide an effective method for evaluating the severity of IgAN.
RESULTS
MiR-223 levels in GEnCs decrease after in vitro incubation with IgA-HMC medium prepared with pIgA from patients with glomerular EP
The clinical features of the enrolled patients are summarized in Table 1 . IgA-HMC medium, which was prepared with pIgA from patients with EP, promoted the proliferation of GEnCs in a dose-and time-dependent way ( Figure 1 ). In contrast, no significant proliferation was observed in cells treated with IgA-HMC medium prepared with pIgA from patients without EP or the medium prepared with monomeric IgA (mIgA) from any source. Cellular apoptosis was not triggered by treatment with IgA-HMC medium prepared with pIgA from patients with EP.
IgA-HMC medium prepared with pIgA from patients with EP modulated the transcription of numerous miRNAs, with the greatest decrease observed in miR-223 ( Figure 1 ). Quantification by reverse transcriptase-PCR (RT-PCR) confirmed the downregulation of miR-223 in GEnCs treated with IgA-HMC medium prepared with pIgA from patients with EP. No significant difference was found in the GEnCs treated with IgA-HMC medium prepared with pIgA from patients without EP or prepared with mIgA from any source.
MiR-223 expression is significantly lower in the GEnCs of patients with glomerular EP Glomerular tissues were separated and collected by laser capture microdissection to identify changes in miR-223 expression in IgAN patients. RT-PCR analysis revealed that miR-223 levels were significantly lower in the glomerular tissues of patients with EP, whereas no significant difference was found between patients without EP and normal controls ( Figure 2) .
In situ hybridization was performed to determine the localization of miR-223. MiR-223 was found to be highly expressed in the GEnCs of normal controls and the levels of this miRNA were clearly reduced in the GEnCs of patients with EP ( Figure 2 ).
MiR-223 inhibits GEnC proliferation induced by mesangialderived IL-6
Treatment with interleukin-6 (IL-6)-neutralizing antibody, but not tumor necrosis factor-a-neutralizing or transforming growth factor-b1-neutralizing antibodies, drastically prevented the decrease of miR-223 ( Figure 3 ). The secretion of IL-6 was increased in HMCs incubated with pIgA from patients with EP. Treatment with recombinant IL-6 at concentration comparable to the diluted IgA-HMC conditioned medium inhibited the expression of miR-223 and promoted cell proliferation. This effect was similar to the effect observed with diluted IgA-HMC medium prepared with pIgA from patients with EP. Treatment with anti-IL-6-neutralizing antibody inhibited the proliferation of GEnCs incubated with IgA-HMC medium prepared with pIgA from patients with EP ( Figure 3 ). The proliferation of GEnCs was further enhanced by miR-223 antisense oligonucleotide (ASO) but was reversed by treatment with miR-223 mimics ( Figure 3 ). These findings suggest that mesangial-derived IL-6 promotes cell proliferation by suppressing miR-223 expression in GEnCs.
MiR-223 suppresses ICAM-1 expression and monocyte-endothelial adhesion induced by mesangial-derived IL-6 in GEnCs Treatment with IgA-HMC medium prepared with pIgA from patients with EP increased the expression of intercellular adhesion molecule-1 (ICAM-1). Recombinant IL-6 at a comparable concentration induced ICAM-1 expression similar to the diluted IgA-HMC medium. An anti-IL-6 antibody blunted this effect in GEnCs incubated with IgA-HMC medium prepared with pIgA from patients with EP. ICAM-1 synthesis in GEnCs exposed to IgA-HMC medium prepared with pIgA from patients with EP was further enhanced by miR-223 ASO but was inhibited by miR-223 mimics (Figure 4) .
A monocyte adhesion assay was performed with THP-1 monocytes and GEnCs. Some fluorescently labeled adherent THP-1 cells were detected on the GEnC monolayer in the control samples, whereas the number of adherent THP-1 cells dramatically increased after incubation with IgA-HMC medium prepared with pIgA from patients with EP. Monocyte-endothelial adhesion in GEnCs was enhanced by miR-223 ASO but inhibited by miR-223 mimics after exposure to IgA-HMC medium prepared with pIgA from patients with EP. Recombinant IL-6 at a comparable concentration increased the number of adherent THP-1 cells, similar to the diluted IgA-HMC medium. In contrast, treatment with an anti-IL-6 antibody reduced monocyte adhesion to the GEnC monolayer. These observations imply that mesangial-derived IL-6 promotes ICAM-1 expression and monocyte-endothelial adhesion by suppressing the expression of miR-223 in GEnCs.
The NF-jB and STAT3 signaling pathways collaborate in the activation of GEnCs IgA-HMC medium prepared with pIgA from patients with EP promoted the phosphorylation of IKKb and the degradation of IkBa, resulting in the nuclear translocation and DNA binding of p65. Recombinant IL-6 at a comparable concentration induced effects, similar to the diluted IgA-HMC medium. In contrast, treatment with the anti-IL-6 antibody blunted the phosphorylation of IKKb, the degradation of IkBa, and the nuclear translocation and DNA binding of p65 in GEnCs treated with IgA-HMC medium prepared with pIgA from patients with EP ( Figure 5 ).
At the same time, IgA-HMC medium prepared with pIgA from patients with EP promoted the phosphorylation of Janus kinase 2 (JAK2) and the nuclear translocation and DNA binding of signal transducer and activator of transcription 3 (STAT3). Recombinant IL-6 at a comparable concentration induced effects similar to the diluted IgA-HMC medium. In contrast, treatment with the anti-IL-6 antibody blunted the phosphorylation of JAK2 and the nuclear translocation and DNA binding of STAT3 in GEnCs incubated with IgA-HMC medium prepared with pIgA from patients with EP.
Treatment with the nuclear factor-kB (NF-kB) inhibitor Bay 11-7085 or the STAT3 inhibitor cucurbitacin I suppressed the cell proliferation, ICAM-1 expression, and monocyte adhesion induced by IgA-HMC medium prepared with pIgA from patients with EP. Concomitant treatment with both of these inhibitors further inhibited these effects. This result suggested that the NF-kB and STAT3 signaling pathways cooperate in mediating cell proliferation and monocyte adhesion in GEnCs treated with IgA-HMC medium prepared with pIgA from patients with EP.
MiR-223 inhibits the nuclear translocation of NF-jB and STAT3 in GEnCs of IgAN
We next investigated the effects of miR-223 on the activation of the NF-kB and STAT3 signaling pathways. MiR-223 mimics inhibited the nuclear translocation and DNA binding of p65, whereas miR-223 ASO promoted the nuclear translocation and DNA binding of p65 after exposure to IgA-HMC medium prepared with pIgA from patients with EP. The miR-223 mimics, miR-223 ASO and the miRNA negative control did not exhibit significant differences in the expression of p65 in the whole-cell lysate or the expression of IKKb, p-IKKb, IkBa, and p-IkBa in the cytoplasmic fraction of cells treated with IgA-HMC medium prepared with pIgA from patients with EP ( Figure 6 ). The miR-223 mimics also inhibited the nuclear translocation and DNA binding of STAT3, whereas miR-223 ASO promoted the nuclear translocation and DNA binding of STAT3 after exposure to IgA-HMC medium prepared with pIgA from patients with EP. The miR-223 mimics, miR-223 ASO, and the miRNA negative control did not exhibit significant differences in the expression of STAT3 in the whole-cell lysate or the expression of JAK2 and p-JAK2 in the cytoplasmic fraction of cells treated with IgA-HMC medium prepared with pIgA from patients with EP.
MiR-223 inhibits NF-jB nuclear translocation by targeting IPOA4 in GEnCs
Web-based miRNA databases predicted that importin a4 might be an important target in the activation of GEnCs, as importin a4 (IPOA4) plays a key role as a biological transducer of NF-kB. Immunohistochemical analysis showed that IPOA4 levels were significantly higher in the glomerular tissues of patients with EP than normal controls ( Figure 7 ). Exposure to IgA-HMC medium prepared with pIgA from patients with EP induced the expression of IPOA4. MiR-223 mimics inhibited the increase in IPOA4 expression, whereas miR-223 ASO further increased the expression of IPOA4 after exposure to IgA-HMC medium prepared with pIgA from patients with EP.
The transfection of miR-223 mimics inhibited the expression of IPOA4 3 0 -untranslated region (UTR)-Luc. In addition, the expression of miR-223 reduced IPOA4 protein levels. There are two potential miR-223-binding sites in the 3 0 -UTR of IPOA4 mRNA. The overexpression of miR-223 decreased the expression of luciferase reporter constructs containing either the site 1 or the site 2 sequence. Site-directed mutations rescued the miR-223-mediated inhibition of IPOA4 3 0 -UTR-Luc. The small interfering RNA-mediated suppression of IPOA4 reduced the nuclear translocation and DNA binding of p65, in addition to suppressing GEnC proliferation and preventing the expression of ICAM-1 and monocyte adhesion in GEnCs exposed to IgA-HMC medium prepared with pIgA from patients with EP, which mimics miR-223 ( Figure 7 ).
MiR-223 inhibits STAT3 nuclear translocation by targeting IPOA5 in GEnCs
Importin a5 was predicted to be another possible important target of miR-223, as importin a5 plays a key role in the (d) The change in the proliferation of GEnCs exposed to IgA-HMC medium or IL-6 (20 ng/ml) plus anti-IL-6 (1 mg/ml). (e) The change in cell proliferation in GEnCs exposed to IgA-HMC medium plus miR-223 mimics or miR-223 antisense oligonucleotide (ASO). BrdU, 5-bromodeoxyuridine; IgAN, IgA nephropathy; IgAN-NEP, IgA-HMC medium prepared with polymeric IgA from patients without glomerular endothelial proliferation; IgAN-EP, IgA-HMC medium prepared with pIgA from patients with glomerular endothelial proliferation; Normal, IgA-HMC medium prepared with pIgA from normal control subjects; TGF-b1, transforming growth factor-b1; TNF-a, tumor necrosis factor-a. *Po0.05 versus normal control; # Po0.05 versus cells exposed to IgA-HMC medium prepared with pIgA from patients with glomerular endothelial proliferation or IL-6.
nuclear transport of STAT3. Immunohistochemical analysis showed that IPOA5 was significantly higher in the glomerular tissues of IgAN patients with EP than normal controls ( Figure 8 ). Exposure to IgA-HMC medium prepared with pIgA from patients with EP induced the expression of IPOA5 in GEnCs. MiR-223 mimics inhibited the increase in IPOA5 levels, whereas miR-223 ASO further increased the expression of IPOA5 after exposure to IgA-HMC medium prepared with pIgA from patients with EP. The transfection of miR-223 mimics significantly inhibited the expression of IPOA5 3 0 -UTR-Luc. In addition, the expression of miR-223 reduced IPOA5 protein levels. There are also two potential miR-223-binding sites in the 3 0 -UTR of IPOA5 mRNA. The overexpression of miR-223 decreased the expression of luciferase-reporter constructs containing either the site 1 or the site 2 sequence. Site-directed mutations rescued the miR-223-mediated inhibition of IPOA5 3 0 -UTR-Luc. The small interfering RNA-mediated suppression of IPOA5 expression reduced the nuclear translocation and DNA binding of STAT3, in addition to suppressing the proliferation of GEnCs and preventing the expression of ICAM-1 and monocyte adhesion in GEnCs exposed to IgA-HMC medium prepared with pIgA from patients with EP, which mimics miR-223 function (Figure 8 ).
MiR-223 levels are reduced in the CECs of patients with glomerular endothelial proliferation CECs are often isolated through the use of magnetic beads coupled to a monoclonal antibody targeting CD146. However, because a subpopulation of endothelial precursor cells and lymphocytes also express CD146 molecules, isolation with anti-CD146 beads alone does not provide a pure population of mature endothelial cells. To obtain purified CECs, the cells were first enriched through the use of anti-CD146 beads. The cells were then negatively selected with anti-CD45 beads and anti-CD133 beads. Immunofluorescence analysis confirmed that the purified cells were primarily
RT-PCR analysis indicated that the miR-223 levels in the CECs of patients with EP were significantly lower than the levels in the CECs from patients without EP and normal controls ( Figure 9 ). The level of miR-223 in CECs correlated with the level of urine protein, number of urine red blood cells, serum creatinine level, glomerular EP score, and the glomerular crescent percentage in patients with IgAN (Table 2) .
DISCUSSION
IgAN represents 440% of the primary glomerular diseases and is the most important cause of end-stage renal failure in China. 2, 9 GEnCs actively participate in the processes Kidney International controlling inflammation, and aberrations in these control mechanisms contribute to the development of disease within the glomerulus. 10 We found that miR-223 levels were significantly lower in the GEnCs of IgAN patients with EP than controls and in in vitro stimulation experiments. Previous studies have investigated the role of miR-223 in the regulation of cell growth. Jia et al. 11 reported that miR-223 significantly suppressed the proliferation and colony formation of HeLa cells in vitro and inhibited tumorigenicity in nude mice in vivo. Pulikkan et al. 12 revealed that miR-223 was downregulated in acute myeloid leukemia, and Dai et al. 13 recently reported that miR-223 is downregulated in the tissues of lupus nephritis. Our findings are also inconsistent with the report made by Shi et al., 14 who found that miR-223 is highly expressed in freshly isolated human umbilical vein endothelial cells and maintains endothelial cells in a nonproliferative phenotype. In IgAN, renal injury is initiated by the deposition of IgA in the glomerular mesangial area. Lai et al. 15, 16 reported that the cytokines released from the mesangium after IgA deposition activate the proliferation of proximal tubular epithelial cells. The degree of histological damages in IgAN increase with the presence of IL-6 in the glomeruli. 17 We found that the level of IL-6 was higher in the HMC conditioned medium prepared with pIgA from patients with EP, and only the medium prepared with pIgA from patients with EP promoted cell proliferation, ICAM-1 expression, and monocyte adhesion. This is inconsistent with the report made by Reterink et al. 18 that dimeric and polymeric IgA, but not monomeric IgA, enhance the production of IL-6 by human mesangial cells. Serum IgA is hypoglycosylated in patients with focal proliferative lesions but not in patients with only mild mesangial proliferation, 19 and both hypoglycosylation and size of IgA are essential for interaction between IgA and mesangial cells. 20, 21 Moura et al. 22 revealed that polymeric but not monomeric IgA interacted with transferrin receptor on human mesangial cells, and sialidase and b-galactosidase treatment of pIgA enhanced IgA/transferrin receptor interaction.
Adhesion between the vascular endothelium and circulating leukocytes is necessary for the recruitment and migration of leukocytes to sites of inflammation. 23 GEnCs normally express adhesion molecules at low levels. 24 Increased glomerular ICAM-1 expression has been identified in IgAN. 25 D'Amico et al. 26 reported that the upregulation of adhesion molecules was associated with severe glomerular inflammation in IgAN. When activated, inflammatory cells bind to endothelial cells via ICAM-1/ lymphocyte function-associated antigen 1 and extravasate into tissues. We found that the expression of ICAM-1 and monocyte-endothelial adhesion in GEnCs was significantly increased by mesangial-derived IL-6. Both of these effects were attenuated by miR-223 mimics but exacerbated by miR-223 inhibition.
IL-6 binds to IL-6R. This IL-6/IL-6R complex recruits and induces the dimerization of gp130 and initiating intracellular signaling. Both the NF-kB and STAT3 signal pathways are then activated. 27, 28 These signaling pathways mediate the cell proliferation and monocyte adhesion observed in GEnCs treated with IgA-HMC medium prepared with pIgA from patients with EP. More importantly, Kesanakurti et al. 29 showed that NF-kB and STAT3 cooperate in the induction of ICAM-1 expression. Supplementation with miR-223 mimics attenuated the activation of the NF-kB and STAT3 signaling pathways in GEnCs treated with IgA-HMC medium prepared with pIgA from patients with EP, whereas miR-223 inhibition exacerbated the activation of these pathways. This finding is consistent with the report that miR-223 supplementation suppresses classic proinflammatory pathways in obesity-associated adipose tissue. 30 Although a recent study has suggested that miR-223 targets STAT3 in macrophages, 31 we were unable to detect a Kidney International change in the total amount of STAT3 in GEnCs treated with IgA-HMC medium prepared with pIgA from patients with EP. This finding was supported by previous reports on the effect of IL-6 in endothelial cells. 27 We were also unable to detect a significant impact of miR-223 on the level of IKKb, p-IKKb, IkBa, p-IkBa, JAK2, and p-JAK2. Instead, we confirmed that importin a4 and importin a5 mediate the effects of miR-223 in IgAN. Importin a4 and importin a5 are the main importin isoforms mediating the translocation of NF-kB and STAT3, respectively, into the nucleus. 32, 33 Treatment with miR-223 mimics inhibits the synthesis of importin a4 and importin a5 and blunts the nuclear translocation of NF-kB and STAT3, thus suppressing the cellular proliferation and monocyte adhesion that are induced by IgA-HMC medium prepared with pIgA from patients with EP.
CECs 'sloughed off ' the vessel walls are an indicator of endothelial damage. 34 CECs are considered a marker of active antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. 35 However, manual cell counting is very time consuming and may introduce experimenter bias. We found that miR-223 levels are decreased in CECs from patients with EP and are closely linked to the clinical and pathological parameters of this disease. ICAM-1) expression, and monocyte-endothelial adhesion in GEnCs exposed to IgA-HMC medium plus IPOA4 siRNA. IgAN-EP, IgA-HMC medium prepared with polymeric IgA from patients with glomerular endothelial proliferation; IgAN-NEP, IgA-HMC medium prepared with pIgA from patients without glomerular endothelial proliferation; Normal, IgA-HMC medium prepared with pIgA from normal control subjects; RLU, relative light units. *Po0.05 versus normal control; # Po0.05 versus cells exposed to IgA-HMC medium prepared with pIgA from patients with glomerular endothelial proliferation.
In conclusion, our study suggests that the downregulation of miR-223 promotes GEnC activation by upregulating importin a4 and importin a5 in IgAN. Monitoring the level of miR-223 in circulating endothelial cells provides a noninvasive method for evaluating the severity of IgAN.
MATERIALS AND METHODS
Patients and control subjects Thirty IgAN patients who underwent renal biopsies at Jinling Hospital were recruited. Sera from 20 healthy age-and sex-matched volunteers served as controls. The study was carried out in accordance with the Declaration of Helsinki Principles and was approved by the ethics committees of Jinling Hospital.
Preparation of IgA-HMC medium
IgA purified using a Jacalin-agarose affinity column was fractionated as described previously. 36 The endotoxin level for IgA preparations was o1 pg per mg protein. Nonreducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis confirmed the purity of mIgA and pIgA ( Figure 10 ). Renal HMCs (ScienCell, Carlsbad, CA) were cultured in the medium supplied by the manufacturer. 37 Growth-arrested HMCs were cultured in medium 
Culture and treatment of GEnCs
Human renal GEnCs (Sciencell)) were grown in the medium supplied by the manufacturer. 38 Different preparations of the IgA-HMC medium were diluted 10-fold with endothelial cell medium containing 0.5% fetal bovine serum. Cell proliferation and death were analyzed with 5-bromodeoxyuridine labeling and detecting kit III and cell death detection ELISAPLUS kit (Roche Applied Science, Indianapolis, IN).
The miRNA PCR array analysis The miRNA from the GEnCs was converted to cDNA using the miRNA first-strand kit. The miRNAs were detected using the Human miFinder miRNA PCR Array (MIHS-001Z; SABiosciences, Frederick, MD). 39 RT-PCR analysis Total RNA was extracted using the mirVana miRNA Isolation Kit (Ambion, Austin, TX). MiR-223 expression was quantified with the Taqman miRNA assay (Applied Biosystems, Foster City, CA). 40 RT-PCR analysis of ICAM-1 was performed using specific primers (ICAM-1 sense, 5 0 -GGCCTCAGTCAGTGTGA-3 0 , ICAM-1 antisense, 5 0 -AACCCCATTCAGCGTCA-3 0 ).
Laser capture microdissection
The samples used to determine miR-223 expression in glomeruli were obtained from patients as described in Table 1 . The control renal tissues were obtained from the intact pole of kidneys that were removed for single circumscribed tumors. Patients aged 450 years, or with hypertension, diabetes, or chronic kidney diseases were excluded, and the tissues were checked to be normal through light microscope. Ten control tissues were collected within past 5 years. The age and male/female ratio of these patients were matched with that of IgAN patients (36.7 ± 7.8 vs. 32.7 ± 9.8 years old, P40.05; 6/4 vs. 15/15, P40.05). Laser capture microdissection procedure was performed on a Leica LMD System (Leica Microsystems, Wetzlar, Germany). Fifty glomerular cross-sections from each patient were microdissected and collected. 41 In situ hybridization analysis of miR-223
In situ hybridization for miR-223 was performed on paraffinembedded tissue sections as previously described. 42, 43 The sections were deparaffinized, rehydrated, and treated with proteinase K before being hybridized with 20 nmol/l DIG-labeled miR-223 probe (Exiqon, Copenhagen, Denmark) at 51 1C for 3 h. The sections were then incubated with anti-DIG-rhodamine at 37 1C for 1 h. Staining for CD31 was carried out using mouse anti-human CD31 and Alexa Fluor 488 goat anti-mouse antibodies (Molecular Probes, Eugene, OR).
Renal histological examination
The renal biopsies were performed under ultrasonographic guidance. The histological parameters were assessed using the measurements previously reported. 44 Double stain of IPOA4 or IPOA5 with CD31 was performed on paraffin-embedded tissues using Fast Blue and 3,3 0 -Diaminobenzidine as chromagens.
ELISA analysis of IL-6
A sandwich enzyme-linked immunosorbent assay (ELISA) was performed according to the manufacturer's protocol (R&D Systems, Minneapolis, MN) to quantitate the IL-6 level. The detection sensitivities were 0.11 pg/ml.
Western blot analysis
Western blots were performed as previously described. 45 The antibodies against JAK2, p-JAK2, STAT3, p-STAT3, IKKb, IkBa, p-IkBa, p65, IPOA5, and b-actin were purchased from Santa Cruz Biotechnology (Santa Cruz, CA), and the antibodies against p-IKKb and IPOA4 were purchased from Abcam (Cambridge, MA), Nuclear and cytoplasmic proteins were extracted using the NE-PER Nuclear and Cytoplasmic Extraction Kit (Pierce, Rockford, IL).
Fluorescent immunohistochemistry of p65 and p-STAT3
GEnCs were fixed in 4% paraformaldehyde. The cells were exposed to anti-p65 or anti-p-STAT3 antibodies for 2 h before being incubated with secondary antibodies diluted in blocker for 45 min. 46 As a negative control, the primary antibody was replaced by nonimmune serum from the same species.
Monocyte-endothelial cell interaction assay THP-1 monocytes were loaded with 2 0 ,7 0 -bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein, acetoxymethyl ester (10 mg/ml) for 30 min at 37 1C and washed twice with phosphate-buffered saline. A total of 50,000 THP-1 monocytes were allowed to adhere to the endothelial monolayer for 1 h. Any cells not adhering were removed by several washes. The remaining adherent cells were lysed and quantified by measuring fluorescence. 47 Alternatively, the adherent cells were analyzed directly under the fluorescence microscope.
Luciferase assays
GEnCs were transiently cotransfected with 0.1 mg of the reporter constructs, 0.02 mg of the Renilla construct, and 10 mmol/l miR-223 mimics or control oligonucleotides. The firefly luciferase activity and Renilla luciferase activity were determined using the DualLuciferase Reporter Assay System (Promega, Madison, WI). 12, 48 Values were normalized using Renilla luciferase.
ChIP analysis of p65 and STAT3 DNA binding Chromatin immunoprecipitation (ChIP) assay was performed with the ChIP-IT Express Magnetic Chromatin Immunoprecipitation kit (Active Motif, Carlsbad, CA) and anti-p65, anti-STAT3, or IgG antibodies. The PCR primer was used to amplify the ICAM-1 promoter region that contains both NF-kB-and STAT3-binding sites as previously reported (sense 5 0 -TAGCCCCTCCTTCCCATAA-3 0 , antisense 5 0 -TGAGTCGGGGTGGGGATT-3 0 ). 29 Isolation and quantification of miR-223 in CECs CECs were isolated using a procedure modified from previous reports. 35, 49 The cell population was enriched using anti-CD146 beads (Dynabeads FlowComp Flexi, Invitrogen, Carlsbad, CA) before the CECs were negatively isolated with anti-CD133 beads and anti-CD45 beads. The level of miR-223 in the CECs was quantified with the TaqMan MicroRNA Cells-to-CT Kit (Ambion).
Statistical analyses
All of the data are expressed as the means ± s.d. The data from multiple groups were analyzed with a one-way analysis of variance followed by the Student-Newman-Keuls test. Data from two groups were compared by t-tests. P-values of o0.05 were considered significant.
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